The EFRO project Anicells 2.0 has concluded, and its findings will be showcased during the ATMP Supply Chain Conference scheduled for February 8th, 2024, in Niel, Belgium, from 1:30 PM to 4:30 PM. Anicells 2.0 has centered its efforts on Advanced Therapy Medicinal Product (ATMP) manufacturing, with a specific focus on the adoption of closed and automated platforms in cell therapy production.
See the full program here
About anicells 2.0: Anicells has rigorously evaluated and implemented various next-generation, closed, and automated platforms within its GMP-certified cleanrooms. These efforts are aimed at providing valuable insights and practical solutions to assist cell therapy developers in effectively integrating these innovative platforms into their development and manufacturing processes.
About the anicells 2.0 session: The event will feature presentations where users of different platforms will share their firsthand experiences. This will be followed by a comprehensive presentation discussing the practical aspects of incorporating these platforms into cell therapy manufacturing, including the considerations of when, why, and how to utilize them effectively.